SCOPE 2023: Clinical Trial Developments

What learning science has taught us about the drivers and predictors of change—and applying those to clinical research practice.

As industry clinical trial partners seek greater patient diversity and operational efficiencies in drug development, our October issue of Applied Clinical Trials explores some of the related outsourcing methods that are emerging.

A data-fueled framework for sponsors and CROs in navigating this shifting terrain.

Overcoming this bias—which affects everything from trial design to data collection—is a critical obligation of clinical research stakeholders.

Industry is turning to enhanced data collection methods in response to high demands for efficiency and profitability.

Recent study compared patient enrollment trends in industry- and federally sponsored oncology trials.